Newswise — The announcement this past week from the Centers for Medicare & Medicaid Services (CMS) that Medicare coverage for at-home blood testing of prothrombin time (PT)/International Normalized Ratio (INR) will be expanded is welcome news to the millions of patients who take anticoagulants daily and will now have easier access to proactive, improved quality of health care. In addition to mechanical heart valve patients (for whom CMS approved weekly self-testing in 2002), the new decision expands coverage of home testing to those patients who take warfarin, an anticoagulant medication, for chronic atrial fibrillation or venous thromboembolism.
Jack Ansell, M.D., expert in hemostasis and thrombosis, Chairman of Medicine of Lenox Hill Hospital and founder of the Anticoagulation Forum, will be the keynote speaker of an online media Web cast, addressing this new CMS decision to expand coverage for INR self testing and the positive effects it will have on new pool of patients and their doctors.
Web Cast Details:Thursday, March 27th, 10 a.m. ET (program time approximately 30 minutes)
Dr. Ansell will present for 15 minutes, with additional time allotted for media Q&A
RSS